Additional resources

	Paul Dolan: Addressing misconceptions in valuing health

Quote from the article: 'I have no doubt that policy should seek to help people to feel as good as they can for as long as they can. This over-arching goal can easily get lost in a world of national targets, performance benchmarks and healthcare league tables. Happiness measures can now provide us with a robust metric that focuses our eyes firmly on the ultimate prize of better lives'.

	Reflection paper on the Regulatory Guidance For The Use Of health -Related Quality Of Life (HRQoL) Measures In The Evaluation Of Medicinal Products

European Medicines Agency (EMA), Commitee for Medicinal Products for Human Use (CHMP), 2005.

The scope of this reflection paper is to discuss the place that a health-related quality of life (HRQL), a specific type of PRO, may have in drug evaluation process and to give some broad recommendations on its use in the context of already existing guidance documents.